Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach

被引:156
作者
Bebb, RA
Anawalt, BD
Christensen, RB
Paulsen, CA
Bremner, WJ
Matsumoto, AM
机构
[1] VET AFFAIRS MED CTR, GERIATR RES EDUC & CLIN CTR 182B, SEATTLE, WA 98108 USA
[2] UNIV WASHINGTON, SCH MED, DEPT MED, DIV GERONTOL & GERIATR MED, SEATTLE, WA 98108 USA
[3] UNIV WASHINGTON, SCH MED, DEPT MED, DIV METAB ENDOCRINOL & NUTR, SEATTLE, WA 98108 USA
[4] UNIV WASHINGTON, SCH MED, POPULAT CTR RES REPROD, SEATTLE, WA 98108 USA
关键词
D O I
10.1210/jc.81.2.757
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies using high dose testosterone (T) administration in normal men as a male contraceptive have resulted in azoospermia rates of only 50-70%. Previous studies of T and progestogen combinations have shown comparable rates of azoospermia, but have been uncontrolled or used T in doses less than that associated with maximal suppression of sperm production. We conducted a randomized, placebo-controlled, single blind trial comparing 6 months of T enanthate administration (100 mg, im, weekly) with the same dose of T enanthate in conjunction with the progestogen levonorgestrel (LNG; 500 mu g, orally, daily) in 36 normal men, aged 20-42 yr (n = 18 in each group). The primary end points were induction of azoospermia pr severe oligospermia (<3 million sperm/mL). The combination of T plus LNG was much more effective in suppressing sperm production than T alone. Sixty-seven percent of the T plus LNG group (12 of 18) and 33% of the T alone group (6 of 18) achieved azoospermia by 6 months (P = 0.06). Severe oligospermia pr azoospermia developed in 94% of the T plus LNG (17 of 18) group compared to 61% of the T alone group (11 of 18; P < 0.05). T plus LNG also suppressed sperm production more rapidly than T alone. Time to azoospermia was 9.9 +/- 1.0 vs. 15.3 +/- 1.9 weeks in the T plus LNG and T alone groups, respectively (mean +/- SEM; P < 0.05). Serum high density lipoprotein cholesterol decreased 21.7 +/- 3.6% in men given T plus LNG (P < 0.05), compared to only a 1.8 +/- 3.8% decrease in men in the T alone group. Average weight gain was 5.3 +/- 0.8 kg in the T plus LNG group and 2.3 +/- 0.9 kg in the T alone group (P < 0.05). Acne and increase in hemoglobin were similar in the two groups. We conclude that combination hormonal therapy with T plus a progestogen might offer a reversible male contraceptive approach with a more rapid onset of action and more reliable induction of both azoospermia and severe-oligospermia than T alone.
引用
收藏
页码:757 / 762
页数:6
相关论文
共 41 条
  • [1] AHSAN R, 1988, LABORATORY METHOD MA
  • [2] ALVAREZSANCHEZ F, 1979, INT J ANDROL, V2, P136
  • [3] [Anonymous], 1990, Lancet, V336, P955
  • [4] COMPARISON OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST PLUS TESTOSTERONE (T) VERSUS-T ALONE AS POTENTIAL MALE CONTRACEPTIVE REGIMENS
    BAGATELL, CJ
    MATSUMOTO, AM
    CHRISTENSEN, RB
    RIVIER, JE
    BREMNER, WJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) : 427 - 432
  • [5] PHYSIOLOGICAL TESTOSTERONE LEVELS IN NORMAL MEN SUPPRESS HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS
    BAGATELL, CJ
    KNOPP, RH
    VALE, WW
    RIVIER, JE
    BREMNER, WJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (12) : 967 - 973
  • [6] METABOLIC AND BEHAVIORAL-EFFECTS OF HIGH-DOSE, EXOGENOUS TESTOSTERONE IN HEALTHY-MEN
    BAGATELL, CJ
    HEIMAN, JR
    MATSUMOTO, AM
    RIVIER, JE
    BREMNER, WJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) : 561 - 567
  • [7] POTENTIAL OF TESTOSTERONE BUCICLATE FOR MALE CONTRACEPTION - ENDOCRINE DIFFERENCES BETWEEN RESPONDERS AND NONRESPONDERS
    BEHRE, HM
    BAUS, S
    KLIESCH, S
    KECK, C
    SIMONI, M
    NIESCHLAG, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (08) : 2394 - 2403
  • [8] FOLLICLE-STIMULATING-HORMONE AND HUMAN SPERMATOGENESIS
    BREMNER, WJ
    MATSUMOTO, AM
    SUSSMAN, AM
    PAULSEN, CA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) : 1044 - 1052
  • [9] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    GARRISON, RJ
    WILSON, PWF
    ABBOTT, RD
    KALOUSDIAN, S
    KANNEL, WB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2835 - 2838
  • [10] PROSPECTS FOR NEW HORMONAL MALE CONTRACEPTIVES
    CUMMINGS, DE
    BREMNER, WJ
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (04) : 893 - 922